Loading company…
TrueSight develops AI-based medical imaging and digital precision surgery solutions.
Founded in 2018 and based in Beijing, China, TrueSight develops medical imaging technology using artificial intelligence. Its products include TrueSight, TrueView, TrueTrace, and an AI-assisted clinical analysis system for new coronary pneumonia. The company raised Series B+ funding in February 2026 from Wuhan Wuchuangyuan Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in